CI vs CNC
The Cigna Group and Centene Corporation, side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CI | CNC |
|---|---|---|
| Revenue | $274.9B | $174.6B |
| Net income | $6.0B | $-6.7B |
| Gross margin | 21.8% | 8.1% |
| Net margin | 2.2% | −3.8% |
| Return on equity | 14.4% | −28.8% |
| Diluted EPS | $22.18 | −$13.53 |
| Dividend / share | $6.04 | — |
| Payout ratio | 27.0% | — |
| Free cash flow | $8.4B | $4.3B |
| Equity | $41.7B | $20.0B |
| Net debt / equity | 0.57× | −0.02× |
| Current ratio | 0.85× | 1.10× |
| Revenue CAGR 5y | 11.4% | 11.0% |
| Profit CAGR 5y | −6.8% | — |
CI bills 1.6× the revenue of CNC, and CNC closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | CI | CNC |
|---|---|---|
| FY2025 | $274.9B | $174.6B |
| FY2024 | $247.1B | $145.5B |
| FY2023 | $195.3B | $140.1B |
| FY2022 | $180.5B | $135.5B |
| FY2021 | $174.1B | $118.0B |
| FY2020 | $160.4B | $103.8B |
| FY2019 | $153.6B | $70.4B |
| FY2018 | $48.6B | $56.4B |
| FY2017 | $41.8B | $45.6B |
| FY2016 | $39.8B | $37.6B |
Net income by year
Bottom line
| Fiscal year | CI | CNC |
|---|---|---|
| FY2025 | $6.0B | $-6.7B |
| FY2024 | $3.4B | $3.3B |
| FY2023 | $5.2B | $2.7B |
| FY2022 | $6.8B | $1.2B |
| FY2021 | $5.4B | $1.3B |
| FY2020 | $8.5B | $1.8B |
| FY2019 | $5.1B | $1.3B |
| FY2018 | $2.6B | $900.0M |
| FY2017 | $2.2B | $828.0M |
| FY2016 | $1.8B | $562.0M |
Advertisement
AdSense · Rectangle 336×280